Dry power inhalers and nebulizer products depend greatly on patient breathing. Testing these products under human-realistic flow rates can provide powerful insights into product performance before reaching clinical endpoint studies.
Proveris Laboratories, performs product testing using proprietary INVIDA® (In Vitro Inhaled Drug Analysis) that provides valuable information for predicting and understanding in vivo performance. Reports include spray visualization of your product within the respiratory tract, and quantitative measurements of drug deposition. Additional testing and applications include:
- Formulation Characterization & Screening
- Uniformity of Delivered Dose
- Uniformity of Delivered Mass
- Inter-/intra-container Through-life Product Testing
- Aerodynamic Assessment of Nebulized Aerosols
- Particle Flight - Dispersion - Deposition Characterization
- Device Characterization, Design & Screening
- Peak Inspiratory Flow Studies
- Total Delivered Dose Content
- Device Resistance Characterization